BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

DNAPrint™ genomics, Inc.

DNAPrint™ genomics, Inc. is a cutting edge company. We are concentrating our efforts in four distinct areas; Pharmacogenomics, Forensics, Genotyping, and Consumer Products. Our aim is to continue to research and develop novel products and services in each of these market areas and to be a leader in genomic-based technologies.
The Company’s core patent applied for and proprietary technologies for efficiently targeting single nucleotide polymorphisms (“SNPs”) enable us to provide novel predictive genetic tests at a significant cost advantage over our competitors.

We have identified and applied for patenteds to cover the maps of certain SNPs that we believe have broad commercial applications. These commercially valuable SNPs are called Ancestry Informative Markers (“AIMs”) and are an integral part of our proprietary Admixture Mapping (“Mapping”) method. With our mapping, we leverage known statistical data about population structure to substantially reduce the number of SNPs analyzed and therefore more cost effectively identify genes responsible for certain traits. Our proprietary data and analytical resources for using AIMs are integral to our strategy of offering DNA tests that provide value in other ways too – from better study design using more traditional methods, and generating valuable predictive results, including a person’s physical characteristics, BioGeographical Ancestry (“BGA”), and predisposition to respond to certain pharmaceutical drugs.


Contact Details:
900 Cocoanut Ave.
Sarasota
Florida
34236
United States of America
Tel:(941) 366-3400
Fax:(941) 952-9770
Email:info@dnaprint.com
WWW:

www.dnaprint.com/




Loading...

BioNews Results for DNAPrint™ genomics, Inc.:

Focus on the World Diabetes Diagnostics Market
Street Insider:  Oct 1 2008 3:25PM Matching: dnaprint genom inc
Omrix Biopharmaceuticals, Inc. Product Pipeline Analysis
Mindbranch:  Sep 5 2008 12:14AM Matching: dnaprint genom inc
High Growth Forecasted for the In Vitro Diagnostics Market Report and Analysis 2008-2023
Interest!ALERT:  Sep 5 2008 8:03PM Matching: dnaprint genom inc

DNAPrint™ genomics, Inc. Patents:

US Patent No.Title
7110885 Efficient methods and apparatus for high-throughput processing of gene sequence data
7107155 Methods for the identification of genetic features for complex genetics classifiers

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 175 times since April 2007, the link to the organisation's website has been followed 33 times

Recent Search Terms used to find this page: DNAPrint method | .

Search for more companies in Sarasota

Search for more companies in Florida



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for DNAPrint™ genomics, Inc.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.